Ethanol infusion for Marshall bundle epicardial connections in Marshall bundle-related atrial tachycardias following atrial fibrillation ablation: The accessibility and success rate of ethanol infusion by using a femoral approach.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
09 2019
Historique:
received: 10 04 2019
revised: 03 06 2019
accepted: 03 06 2019
pubmed: 13 6 2019
medline: 17 6 2020
entrez: 13 6 2019
Statut: ppublish

Résumé

Ethanol infusion of the vein of Marshall (VOM) may be effective to treat Marshall bundle-related atrial tachycardia (MB-AT). However, methods and clinical results of ethanol infusion for MB-AT have been not established. To assess the accessibility of the VOM and the success rate of ethanol infusion using a femoral approach for MB-AT. A single-center observational study included consecutive patients who had MB-AT and in whom we attempted to treat MB-AT during AT by ethanol infusion. When the VOM was able to be cannulated following VOM venogram using a femoral approach, we systematically performed ethanol infusion with selective balloon occlusion of the VOM. We analyzed in detail the efficacy of ethanol infusion of VOM in patients who were in MB-AT during ethanol infusion. We enrolled 54 consecutive patients in whom we attempted to treat MB-AT by ethanol infusion. Of those, the VOM was accessible in 92.5% of patients (50 of 54). Of the 50 patients treated by ethanol infusion during MB-AT, AT was successfully terminated in 56% percent of the patients (28 of 50) by solo treatment of ethanol infusion without RF ablation. The remainder required additional RF application to terminate the MB-AT. A mean of 6.2 ± 2.8 mL of ethanol was infused resulting in the low-voltage area significantly larger than that before ethanol infusion (12.7 ± 8.3 vs 6.6 ± 5.3 cm The present study demonstrated that the VOM was highly accessible and MB-AT was amenable to treatment by ethanol infusion by using a femoral approach.

Sections du résumé

BACKGROUND
Ethanol infusion of the vein of Marshall (VOM) may be effective to treat Marshall bundle-related atrial tachycardia (MB-AT). However, methods and clinical results of ethanol infusion for MB-AT have been not established.
OBJECTIVE
To assess the accessibility of the VOM and the success rate of ethanol infusion using a femoral approach for MB-AT.
METHODS
A single-center observational study included consecutive patients who had MB-AT and in whom we attempted to treat MB-AT during AT by ethanol infusion. When the VOM was able to be cannulated following VOM venogram using a femoral approach, we systematically performed ethanol infusion with selective balloon occlusion of the VOM. We analyzed in detail the efficacy of ethanol infusion of VOM in patients who were in MB-AT during ethanol infusion.
RESULTS
We enrolled 54 consecutive patients in whom we attempted to treat MB-AT by ethanol infusion. Of those, the VOM was accessible in 92.5% of patients (50 of 54). Of the 50 patients treated by ethanol infusion during MB-AT, AT was successfully terminated in 56% percent of the patients (28 of 50) by solo treatment of ethanol infusion without RF ablation. The remainder required additional RF application to terminate the MB-AT. A mean of 6.2 ± 2.8 mL of ethanol was infused resulting in the low-voltage area significantly larger than that before ethanol infusion (12.7 ± 8.3 vs 6.6 ± 5.3 cm
CONCLUSION
The present study demonstrated that the VOM was highly accessible and MB-AT was amenable to treatment by ethanol infusion by using a femoral approach.

Identifiants

pubmed: 31187516
doi: 10.1111/jce.14019
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1443-1451

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Takeshi Kitamura (T)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Konstantinos Vlachos (K)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Arnaud Denis (A)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Clementine Andre (C)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Ruairidh Martin (R)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Thomas Pambrun (T)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Josselin Duchateau (J)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Antonio Frontera (A)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Masateru Takigawa (M)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Nathaniel Thompson (N)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Ghassen Cheniti (G)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Claire A Martin (CA)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Anna Lam (A)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Felix Bourier (F)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Frederic Sacher (F)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Meleze Hocini (M)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Michel Haissaguerre (M)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Pierre Jais (P)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Nicolas Derval (N)

CHU de Bordeaux, LIRYC, University of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH